T. Rowe Price US Large Cap Growth Equity Fund A USD vs SEB Bioteknikfond D

T. Rowe Price US Large Cap Growth Equity Fund A USD vs SEB Bioteknikfond D

1. T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Security

    T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Fee

    1.59%

  • ISIN

    LU0174119429

  • Holdings

    10

2. SEB Bioteknikfond D

  • Security

    SEB Bioteknikfond D EUR Lux Utd

  • Fee

    1.69%

  • ISIN

    LU0118405827

  • Holdings

    24

Fund Holdings

We have information about 20 holdings in T. Rowe Price US Large Cap Growth Equity Fund A USD, where the largest holding is Apple (9.72), followed by Microsoft (9.66) and Nvidia (8.48). In comparison with SEB Bioteknikfond D, we have 24 holdings where Gilead Sciences is the largest holding (10.04), followed by Vertex (8.8) and Amgen (8.54).

All Holdings

Here we compare the holdings in T. Rowe Price US Large Cap Growth Equity Fund A USD and SEB Bioteknikfond D.

T. Rowe Price US Large Cap Growth Equity Fund A USD SEB Bioteknikfond D
1. Apple Inc
USA
9.72 %
1. Gilead Sciences Inc
USA
10.04 %
2. Microsoft Corp
USA
9.66 %
2. Vertex Pharmaceuticals Inc
8.8 %
3. Nvidia Corp
USA
8.48 %
3. Amgen Inc
8.54 %
4. Amazon.com Inc
USA
7.9 %
4. Regeneron Pharmaceuticals Inc
5.09 %
5. Alphabet Inc Class A
USA
4.7 %
5. Alnylam Pharmaceuticals Inc
5.07 %
6. Meta Platforms A
USA
4.66 %
6. AstraZeneca ADR
Sweden UK
4.49 %
7. Mastercard Inc
USA
3.72 %
7. Verona Pharma ADR
3.46 %
8. Intuit Inc
3.31 %
8. Argenx ADR
2.72 %
9. ServiceNow Inc
USA
2.9 %
9. Illumina Inc
2.72 %
10. Visa Inc
USA
2.77 %
10. BioNTech SE
2.41 %
- 11. Madrigal Pharmaceuticals Inc
1.88 %
- 12. BoneSupport AB
Sweden
1.82 %
- 13. BioMarin Pharmaceutical Inc
1.7 %
- 14. Krystal Biotech Inc
1.48 %
- 15. NewAmsterdam Pharma NV
1.46 %
- 16. BridgeBio Pharma Inc
1.45 %
- 17. Cytokinetics Inc
1.4 %
- 18. Ionis Pharmaceuticals Inc
1.37 %
- 19. Xenon Pharmaceuticals
1.37 %
- 20. Insmed Inc
1.32 %
- 21. Onward Medical NV
1.31 %
- 22. Janux Therapeutics Inc
1.3 %
- 23. Structure Therapeutics ADR
1.24 %
- 24. Kymera Therapeutics Inc
1.09 %

The list of fund holdings was last updated on June 6, 2025.